This platform and its APIs have reached their end of life and will be switched-off at the end of May 2024.

Data are not updated anymore. We invite you to use instead our new data dissemination platform OECD Data Explorer.

To find the corresponding OECD Data Explorer dataset, see this Excel file.

Go!
Country
Year20142015201620172018201920202021
VariableMeasure
Total pharmaceutical consumptionInformation on itemA-Alimentary tract and metabolismInformation on itemDefined daily dosage per 1 000 inhabitants per day
(D151.9
(D151.3
(D149.5
(D149.3
(D150.8
(D144.2
(D139.2
(D143.1
A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)Information on item
(D77.8
(D77.5
(D78
(D77.3
(D76
(D68.3
(D62.4
(D63.9
A10-Drugs used in diabetesInformation on item
(D57.5
(D57.5
(D56.7
(D57.1
(D57.8
(D57.5
(D60
(D62.4
B-Blood and blood forming organsInformation on item
(D45
(D46.1
(D35.4
(D36.3
(D37.4
(D37.7
(D38.7
(D39.9
C-Cardiovascular systemInformation on item
(D380.3
(D376.3
(D371.3
(D368.5
(D371.6
(D371.7
(D383.8
(D395.4
C01A-Cardiac glycosidesInformation on item
(D2.9
(D2.7
(D2.5
(D2.4
(D2.3
(D2.1
(D2.1
(D2
C01B-Antiarrhythmics, Class I and IIIInformation on item
(D1.9
(D2
(D2
(D2
(D2.1
(D2.2
(D2.2
(D2.3
C02-AntihypertensivesInformation on item
(D7.8
(D7.8
(D8
(D8
(D8.2
(D8.6
(D9.2
(D9.7
C03-DiureticsInformation on item
(D26.1
(D25.7
(D25.2
(D25.2
(D24.9
(D24.6
(D25.3
(D25.2
C07-Beta blocking agentsInformation on item
(D26.3
(D26
(D25.8
(D25.5
(D25.5
(D25.3
(D25.8
(D26
C08-Calcium channel blockersInformation on item
(D41.9
(D40.4
(D39.2
(D38.3
(D38
(D37.6
(D38.8
(D39.6
C09-Agents acting on the Renin-Angiotensin systemInformation on item
(D132.6
(D129.1
(D126.9
(D125.2
(D124.5
(D123.7
(D126.1
(D128.7
C10-Lipid modifying agentsInformation on item
(D131.6
(D134
(D133.5
(D134.1
(D138.8
(D140.7
(D147.4
(D155.3
G-Genito urinary system and sex hormonesInformation on item
(D29.9
(D29.9
(D29.8
(D30
(D29.9
(D30.2
(D30
(D29.4
G03-Sex hormones and modulators of the genital systemInformation on item
(D27.9
(D27.9
(D27.8
(D28
(D27.9
(D28.2
(D27.9
(D27.3
H-Systemic hormonal preparations, excluding sex hormones and insulinsInformation on item
(D39.5
(D40.7
(D41.3
(D41.5
(D41
(D41.5
(D39.6
(D39.5
J-Antiinfectives for systemic useInformation on item
(D21
(D21
(D20.8
(D20.2
(D19.5
(D19.9
(D16.4
(D16.9
J01-Antibacterials for systemic useInformation on item
(D18.8
(D18.8
(D18.3
(D17.8
(D17.2
(D17.6
(D14.2
(D14.6
M-Musculo-skeletal systemInformation on item
(D42.2
(D43.5
(D44.7
(D46
(D48.8
(D49.9
(D51.2
(D52.4
M01A-Antiinflammatory and antirheumatic products non-steroidsInformation on item
(D22.3
(D22
(D21.6
(D20.8
(D20.6
(D19.9
(D19.5
(D18.8
N-Nervous systemInformation on item
(D196.6
(D203.3
(D180.1
(D181.9
(D185
(D187.1
(D194.1
(D200
N02-AnalgesicsInformation on item
(D43.2
(D45.1
(D18.3
(D17.5
(D17.2
(D16.4
16
(D15.4
N05B-AnxiolyticsInformation on item
(D10.2
(D9.6
(D9.3
(D8.1
(D7.6
(D7
6.7
(D6.2
N05C-Hypnotics and sedativesInformation on item
(D4.5
(D4.2
(D3.9
(D3.7
(D3.5
(D3.2
2.9
(D2.7
N06A-AntidepressantsInformation on item
(D100.7
(D104.1
(D106.5
(D109.3
(D112.2
(D115.6
122.2
(D127.9
R-Respiratory systemInformation on item
(D38.1
(D37.5
(D36.1
(D35.8
(D33.4
(D32.2
33.4
(D29.7
R03-Drugs for obstructive airway diseasesInformation on item
(D37.3
(D36.7
(D35.4
(D35.2
(D33
(D31.9
33.1
(D29.4
Total pharmaceutical salesInformation on itemTotal pharmaceutical salesInformation on itemMillion of national currency units
(D11 888
(D12 284
(D15 305
(D14 774
(D14 905
(D15 559
(D16 614
(D17 556
Million US$ at exchange rate
(D10 716.1
(D9 228.5
(D11 377.4
(D11 323.2
(D11 136.3
(D10 816.1
(D11 433.6
(D13 187.9
Million US$, purchasing power parity
(D8 184.6
(D8 335.5
(D10 554
(D9 999
(D10 136.7
(D10 513.7
(D11 426.7
(D12 127.8
/capita, US$ exchange rate
(D456.5
(D387.5
(D470.3
(D460.4
(D446
(D426.8
(D445.7
(D513.4
/capita, US$ purchasing power parity
(D348.6
(D350
(D436.3
(D406.6
(D406
(D414.9
(D445.4
(D472.1
A-Alimentary tract and metabolismInformation on itemMillion of national currency units
(D1 351
(D1 353
(D1 383
(D1 424
(D1 410
(D1 415
(D1 493
(D1 634
Million US$ at exchange rate
(D1 217.8
(D1 016.5
(D1 028.1
(D1 091.4
(D1 053.5
(D983.7
(D1 027.5
(D1 227.4
Million US$, purchasing power parity
(D930.1
(D918.1
(D953.7
(D963.8
(D958.9
(D956.2
(D1 026.9
(D1 128.8
/capita, US$ exchange rate
(D51.9
(D42.7
(D42.5
(D44.4
(D42.2
(D38.8
(D40
(D47.8
/capita, US$ purchasing power parity
(D39.6
(D38.5
(D39.4
(D39.2
(D38.4
(D37.7
(D40
(D43.9
% of total sales
(D11.4
(D11
(D9
(D9.6
(D9.5
(D9.1
(D9
(D9.3
A02A-AntacidsInformation on itemMillion of national currency units
(D1
(D2
(D0
(D0
(D0
(D0
(D0
(D0
Million US$ at exchange rate
(D0.9
(D1.5
(D0
(D0
(D0
(D0
(D0
(D0
Million US$, purchasing power parity
(D0.7
(D1.4
(D0
(D0
(D0
(D0
(D0
(D0
/capita, US$ exchange rate
(D0
(D0.1
(D0
(D0
(D0
(D0
(D0
(D0
/capita, US$ purchasing power parity
(D0
(D0.1
(D0
(D0
(D0
(D0
(D0
(D0
% of total sales
(D0
(D0
(D0
(D0
(D0
(D0
(D0
(D0
A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)Information on itemMillion of national currency units
(D532
(D492
(D486
(D452
(D406
(D378
(D376
(D394
Million US$ at exchange rate
(D479.6
(D369.6
(D361.3
(D346.4
(D303.3
(D262.8
(D258.8
(D296
Million US$, purchasing power parity
(D366.3
(D333.9
(D335.1
(D305.9
(D276.1
(D255.4
(D258.6
(D272.2
/capita, US$ exchange rate
(D20.4
(D15.5
(D14.9
(D14.1
(D12.1
(D10.4
(D10.1
(D11.5
/capita, US$ purchasing power parity
(D15.6
(D14
(D13.9
(D12.4
(D11.1
(D10.1
(D10.1
(D10.6
% of total sales
(D4.5
(D4
(D3.2
(D3.1
(D2.7
(D2.4
(D2.3
(D2.2
A10-Drugs used in diabetesInformation on itemMillion of national currency units
(D589
(D617
(D648
(D718
(D747
(D784
(D868
(D977
Million US$ at exchange rate
(D530.9
(D463.5
(D481.7
(D550.3
(D558.1
(D545
(D597.3
(D733.9
Million US$, purchasing power parity
(D405.5
(D418.7
(D446.8
(D485.9
(D508
(D529.8
(D597
(D674.9
/capita, US$ exchange rate
(D22.6
(D19.5
(D19.9
(D22.4
(D22.4
(D21.5
(D23.3
(D28.6
/capita, US$ purchasing power parity
(D17.3
(D17.6
(D18.5
(D19.8
(D20.3
(D20.9
(D23.3
(D26.3
% of total sales
(D5
(D5
(D4.2
(D4.9
(D5
(D5
(D5.2
(D5.6
B-Blood and blood forming organsInformation on itemMillion of national currency units
(D545
(D617
(D667
(D748
(D816
(D880
(D947
(D1 022
Million US$ at exchange rate
(D491.3
(D463.5
(D495.8
(D573.3
(D609.7
(D611.7
(D651.7
(D767.7
Million US$, purchasing power parity
(D375.2
(D418.7
(D460
(D506.2
(D554.9
(D594.6
(D651.3
(D706
/capita, US$ exchange rate
(D20.9
(D19.5
(D20.5
(D23.3
(D24.4
(D24.1
(D25.4
(D29.9
/capita, US$ purchasing power parity
(D16
(D17.6
(D19
(D20.6
(D22.2
(D23.5
(D25.4
(D27.5
% of total sales
(D4.6
(D5
(D4.4
(D5.1
(D5.5
(D5.7
(D5.7
(D5.8
C-Cardiovascular systemInformation on itemMillion of national currency units
(D2 200
(D1 992
(D1 860
(D1 798
(D1 822
(D1 862
(D1 962
(D2 061
Million US$ at exchange rate
(D1 983.1
(D1 496.5
(D1 382.7
(D1 378
(D1 361.3
(D1 294.4
(D1 350.2
(D1 548.2
Million US$, purchasing power parity
(D1 514.6
(D1 351.7
(D1 282.6
(D1 216.9
(D1 239.1
(D1 258.2
(D1 349.4
(D1 423.8
/capita, US$ exchange rate
(D84.5
(D62.8
(D57.2
(D56
(D54.5
(D51.1
(D52.6
(D60.3
/capita, US$ purchasing power parity
(D64.5
(D56.8
(D53
(D49.5
(D49.6
(D49.7
(D52.6
(D55.4
% of total sales
(D18.5
(D16.2
(D12.2
(D12.2
(D12.2
(D12
(D11.8
(D11.7
C01A-Cardiac glycosidesInformation on itemMillion of national currency units
(D4
(D5
(D5
(D5
(D5
(D5
(D5
(D5
Million US$ at exchange rate
(D3.6
(D3.8
(D3.7
(D3.8
(D3.7
(D3.5
(D3.4
(D3.8
Million US$, purchasing power parity
(D2.8
(D3.4
(D3.4
(D3.4
(D3.4
(D3.4
(D3.4
(D3.5
/capita, US$ exchange rate
(D0.2
(D0.2
(D0.2
(D0.2
(D0.1
(D0.1
(D0.1
(D0.1
/capita, US$ purchasing power parity
(D0.1
(D0.1
(D0.1
(D0.1
(D0.1
(D0.1
(D0.1
(D0.1
% of total sales
(D0
(D0
(D0
(D0
(D0
(D0
(D0
(D0
C01B-Antiarrhythmics, Class I and IIIInformation on itemMillion of national currency units
(D19
(D19
(D20
(D20
(D21
(D22
(D24
(D26
Million US$ at exchange rate
(D17.1
(D14.3
(D14.9
(D15.3
(D15.7
(D15.3
(D16.5
(D19.5
Million US$, purchasing power parity
(D13.1
(D12.9
(D13.8
(D13.5
(D14.3
(D14.9
(D16.5
(D18
/capita, US$ exchange rate
(D0.7
(D0.6
(D0.6
(D0.6
(D0.6
(D0.6
(D0.6
(D0.8
/capita, US$ purchasing power parity
(D0.6
(D0.5
(D0.6
(D0.6
(D0.6
(D0.6
(D0.6
(D0.7
% of total sales
(D0.2
(D0.2
(D0.1
(D0.1
(D0.1
(D0.1
(D0.1
(D0.1
C02-AntihypertensivesInformation on itemMillion of national currency units
(D83
(D91
(D98
(D107
(D116
(D134
(D150
(D169
Million US$ at exchange rate
(D74.8
(D68.4
(D72.9
(D82
(D86.7
(D93.2
(D103.2
(D127
Million US$, purchasing power parity
(D57.1
(D61.7
(D67.6
(D72.4
(D78.9
(D90.5
(D103.2
(D116.7
/capita, US$ exchange rate
(D3.2
(D2.9
(D3
(D3.3
(D3.5
(D3.7
(D4
(D4.9
/capita, US$ purchasing power parity
(D2.4
(D2.6
(D2.8
(D2.9
(D3.2
(D3.6
(D4
(D4.5
% of total sales
(D0.7
(D0.7
(D0.6
(D0.7
(D0.8
(D0.9
(D0.9
(D1
C03-DiureticsInformation on itemMillion of national currency units
(D38
(D43
(D46
(D48
(D49
(D54
(D62
(D65
Million US$ at exchange rate
(D34.3
(D32.3
(D34.2
(D36.8
(D36.6
(D37.5
(D42.7
(D48.8
Million US$, purchasing power parity
(D26.2
(D29.2
(D31.7
(D32.5
(D33.3
(D36.5
(D42.6
(D44.9
/capita, US$ exchange rate
(D1.5
(D1.4
(D1.4
(D1.5
(D1.5
(D1.5
(D1.7
(D1.9
/capita, US$ purchasing power parity
(D1.1
(D1.2
(D1.3
(D1.3
(D1.3
(D1.4
(D1.7
(D1.7
% of total sales
(D0.3
(D0.4
(D0.3
(D0.3
(D0.3
(D0.3
(D0.4
(D0.4
C07-Beta blocking agentsInformation on itemMillion of national currency units
(D142
(D144
(D153
(D153
(D158
(D163
(D176
(D187
Million US$ at exchange rate
(D128
(D108.2
(D113.7
(D117.3
(D118.1
(D113.3
(D121.1
(D140.5
Million US$, purchasing power parity
(D97.8
(D97.7
(D105.5
(D103.5
(D107.5
(D110.1
(D121
(D129.2
/capita, US$ exchange rate
(D5.5
(D4.5
(D4.7
(D4.8
(D4.7
(D4.5
(D4.7
(D5.5
/capita, US$ purchasing power parity
(D4.2
(D4.1
(D4.4
(D4.2
(D4.3
(D4.3
(D4.7
(D5
% of total sales
(D1.2
(D1.2
(D1
(D1
(D1.1
(D1
(D1.1
(D1.1
C08-Calcium channel blockersInformation on itemMillion of national currency units
(D119
(D124
(D133
(D130
(D132
(D134
(D142
(D148
Million US$ at exchange rate
(D107.3
(D93.2
(D98.9
(D99.6
(D98.6
(D93.2
(D97.7
(D111.2
Million US$, purchasing power parity
(D81.9
(D84.1
(D91.7
(D88
(D89.8
(D90.5
(D97.7
(D102.2
/capita, US$ exchange rate
(D4.6
(D3.9
(D4.1
(D4.1
(D4
(D3.7
(D3.8
(D4.3
/capita, US$ purchasing power parity
(D3.5
(D3.5
(D3.8
(D3.6
(D3.6
(D3.6
(D3.8
(D4
% of total sales
(D1
(D1
(D0.9
(D0.9
(D0.9
(D0.9
(D0.9
(D0.8
C09-Agents acting on the Renin-Angiotensin systemInformation on itemMillion of national currency units
(D706
(D679
(D636
(D598
(D624
(D654
(D705
(D757
Million US$ at exchange rate
(D636.4
(D510.1
(D472.8
(D458.3
(D466.2
(D454.6
(D485.2
(D568.6
Million US$, purchasing power parity
(D486.1
(D460.7
(D438.6
(D404.7
(D424.4
(D441.9
(D484.9
(D522.9
/capita, US$ exchange rate
(D27.1
(D21.4
(D19.5
(D18.6
(D18.7
(D17.9
(D18.9
(D22.1
/capita, US$ purchasing power parity
(D20.7
(D19.3
(D18.1
(D16.5
(D17
(D17.4
(D18.9
(D20.4
% of total sales
(D5.9
(D5.5
(D4.2
(D4
(D4.2
(D4.2
(D4.2
(D4.3
C10-Lipid modifying agentsInformation on itemMillion of national currency units
(D1 028
(D820
(D709
(D674
(D657
(D639
(D642
(D646
Million US$ at exchange rate
(D926.7
(D616
(D527.1
(D516.6
(D490.9
(D444.2
(D441.8
(D485.3
Million US$, purchasing power parity
(D707.8
(D556.4
(D488.9
(D456.2
(D446.8
(D431.8
(D441.6
(D446.3
/capita, US$ exchange rate
(D39.5
(D25.9
(D21.8
(D21
(D19.7
(D17.5
(D17.2
(D18.9
/capita, US$ purchasing power parity
(D30.1
(D23.4
(D20.2
(D18.5
(D17.9
(D17
(D17.2
(D17.4
% of total sales
(D8.6
(D6.7
(D4.6
(D4.6
(D4.4
(D4.1
(D3.9
(D3.7
G-Genito urinary system and sex hormonesInformation on itemMillion of national currency units
(D240
(D298
(D359
(D362
(D367
(D383
(D404
(D438
Million US$ at exchange rate
(D216.3
(D223.9
(D266.9
(D277.4
(D274.2
(D266.2
(D278
(D329
Million US$, purchasing power parity
(D165.2
(D202.2
(D247.6
(D245
(D249.6
(D258.8
(D277.9
(D302.6
/capita, US$ exchange rate
(D9.2
(D9.4
(D11
(D11.3
(D11
(D10.5
(D10.8
(D12.8
/capita, US$ purchasing power parity
(D7
(D8.5
(D10.2
(D10
(D10
(D10.2
(D10.8
(D11.8
% of total sales
(D2
(D2.4
(D2.3
(D2.5
(D2.5
(D2.5
(D2.4
(D2.5
G03-Sex hormones and modulators of the genital systemInformation on itemMillion of national currency units
(D167
(D220
(D278
(D271
(D272
(D282
(D295
(D321
Million US$ at exchange rate
(D150.5
(D165.3
(D206.7
(D207.7
(D203.2
(D196
(D203
(D241.1
Million US$, purchasing power parity
(D115
(D149.3
(D191.7
(D183.4
(D185
(D190.6
(D202.9
(D221.7
/capita, US$ exchange rate
(D6.4
(D6.9
(D8.5
(D8.4
(D8.1
(D7.7
(D7.9
(D9.4
/capita, US$ purchasing power parity
(D4.9
(D6.3
(D7.9
(D7.5
(D7.4
(D7.5
(D7.9
(D8.6
% of total sales
(D1.4
(D1.8
(D1.8
(D1.8
(D1.8
(D1.8
(D1.8
(D1.8
H-Systemic hormonal preparations, excluding sex hormones and insulinsInformation on itemMillion of national currency units
(D168
(D191
(D224
(D237
(D246
(D258
(D264
(D272
Million US$ at exchange rate
(D151.4
(D143.5
(D166.5
(D181.6
(D183.8
(D179.4
(D181.7
(D204.3
Million US$, purchasing power parity
(D115.7
(D129.6
(D154.5
(D160.4
(D167.3
(D174.3
(D181.6
(D187.9
/capita, US$ exchange rate
(D6.5
(D6
(D6.9
(D7.4
(D7.4
(D7.1
(D7.1
(D8
/capita, US$ purchasing power parity
(D4.9
(D5.4
(D6.4
(D6.5
(D6.7
(D6.9
(D7.1
(D7.3
% of total sales
(D1.4
(D1.6
(D1.5
(D1.6
(D1.7
(D1.7
(D1.6
(D1.5
J-Antiinfectives for systemic useInformation on itemMillion of national currency units
(D801
(D822
(D3 422
(D2 540
(D1 794
(D1 378
(D1 133
(D1 030
Million US$ at exchange rate
(D722
(D617.5
(D2 543.8
(D1 946.7
(D1 340.4
(D957.9
(D779.7
(D773.7
Million US$, purchasing power parity
(D551.5
(D557.8
(D2 359.7
(D1 719.1
(D1 220.1
(D931.2
(D779.3
(D711.5
/capita, US$ exchange rate
(D30.8
(D25.9
(D105.2
(D79.2
(D53.7
(D37.8
(D30.4
(D30.1
/capita, US$ purchasing power parity
(D23.5
(D23.4
(D97.5
(D69.9
(D48.9
(D36.7
(D30.4
(D27.7
% of total sales
(D6.7
(D6.7
(D22.4
(D17.2
(D12
(D8.9
(D6.8
(D5.9
J01-Antibacterials for systemic useInformation on itemMillion of national currency units
(D320
(D363
(D392
(D395
(D389
(D400
(D311
(D323
Million US$ at exchange rate
(D288.5
(D272.7
(D291.4
(D302.7
(D290.6
(D278.1
(D214
(D242.6
Million US$, purchasing power parity
(D220.3
(D246.3
(D270.3
(D267.3
(D264.6
(D270.3
(D213.9
(D223.1
/capita, US$ exchange rate
(D12.3
(D11.5
(D12
(D12.3
(D11.6
(D11
(D8.3
(D9.4
/capita, US$ purchasing power parity
(D9.4
(D10.3
(D11.2
(D10.9
(D10.6
(D10.7
(D8.3
(D8.7
% of total sales
(D2.7
(D3
(D2.6
(D2.7
(D2.6
(D2.6
(D1.9
(D1.8
M-Musculo-skeletal systemInformation on itemMillion of national currency units
(D383
(D401
(D426
(D429
(D500
(D535
(D570
(D584
Million US$ at exchange rate
(D345.2
(D301.3
(D316.7
(D328.8
(D373.6
(D371.9
(D392.3
(D438.7
Million US$, purchasing power parity
(D263.7
(D272.1
(D293.8
(D290.3
(D340
(D361.5
(D392
(D403.4
/capita, US$ exchange rate
(D14.7
(D12.6
(D13.1
(D13.4
(D15
(D14.7
(D15.3
(D17.1
/capita, US$ purchasing power parity
(D11.2
(D11.4
(D12.1
(D11.8
(D13.6
(D14.3
(D15.3
(D15.7
% of total sales
(D3.2
(D3.3
(D2.8
(D2.9
(D3.4
(D3.4
(D3.4
(D3.3
M01A-Antiinflammatory and antirheumatic products non-steroidsInformation on itemMillion of national currency units
(D122
(D119
(D115
(D104
(D104
(D102
(D103
(D103
Million US$ at exchange rate
(D110
(D89.4
(D85.5
(D79.7
(D77.7
(D70.9
(D70.9
(D77.4
Million US$, purchasing power parity
(D84
(D80.7
(D79.3
(D70.4
(D70.7
(D68.9
(D70.8
(D71.2
/capita, US$ exchange rate
(D4.7
(D3.8
(D3.5
(D3.2
(D3.1
(D2.8
(D2.8
(D3
/capita, US$ purchasing power parity
(D3.6
(D3.4
(D3.3
(D2.9
(D2.8
(D2.7
(D2.8
(D2.8
% of total sales
(D1
(D1
(D0.8
(D0.7
(D0.7
(D0.7
(D0.6
(D0.6
N-Nervous systemInformation on itemMillion of national currency units
(D1 924
(D1 926
(D1 899
(D1 920
(D1 944
(D1 940
(D2 007
(D2 072
Million US$ at exchange rate
(D1 734.3
(D1 446.9
(D1 411.7
(D1 471.5
(D1 452.5
(D1 348.6
(D1 381.2
(D1 556.5
Million US$, purchasing power parity
(D1 324.6
(D1 306.9
(D1 309.5
(D1 299.4
(D1 322.1
(D1 310.9
(D1 380.4
(D1 431.4
/capita, US$ exchange rate
(D73.9
(D60.8
(D58.4
(D59.8
(D58.2
(D53.2
(D53.8
(D60.6
/capita, US$ purchasing power parity
(D56.4
(D54.9
(D54.1
(D52.8
(D53
(D51.7
(D53.8
(D55.7
% of total sales
(D16.2
(D15.7
(D12.4
(D13
(D13
(D12.5
(D12.1
(D11.8
N02-AnalgesicsInformation on itemMillion of national currency units
(D516
(D554
(D497
(D512
(D516
(D499
(D498
(D525
Million US$ at exchange rate
(D465.1
(D416.2
(D369.5
(D392.4
(D385.5
(D346.9
(D342.7
(D394.4
Million US$, purchasing power parity
(D355.3
(D375.9
(D342.7
(D346.5
(D350.9
(D337.2
(D342.5
(D362.7
/capita, US$ exchange rate
(D19.8
(D17.5
(D15.3
(D16
(D15.4
(D13.7
(D13.4
(D15.4
/capita, US$ purchasing power parity
(D15.1
(D15.8
(D14.2
(D14.1
(D14.1
(D13.3
(D13.4
(D14.1
% of total sales
(D4.3
(D4.5
(D3.2
(D3.5
(D3.5
(D3.2
(D3
(D3
N05B-AnxiolyticsInformation on itemMillion of national currency units
(D33
(D39
(D45
(D48
(D50
(D48
(D48
(D46
Million US$ at exchange rate
(D29.7
(D29.3
(D33.5
(D36.8
(D37.4
(D33.4
(D33
(D34.6
Million US$, purchasing power parity
(D22.7
(D26.5
(D31
(D32.5
(D34
(D32.4
(D33
(D31.8
/capita, US$ exchange rate
(D1.3
(D1.2
(D1.4
(D1.5
(D1.5
(D1.3
(D1.3
(D1.3
/capita, US$ purchasing power parity
(D1
(D1.1
(D1.3
(D1.3
(D1.4
(D1.3
(D1.3
(D1.2
% of total sales
(D0.3
(D0.3
(D0.3
(D0.3
(D0.3
(D0.3
(D0.3
(D0.3
N05C-Hypnotics and sedativesInformation on itemMillion of national currency units
(D21
(D24
(D28
(D28
(D28
(D27
(D26
(D24
Million US$ at exchange rate
(D18.9
(D18
(D20.8
(D21.5
(D20.9
(D18.8
(D17.9
(D18
Million US$, purchasing power parity
(D14.5
(D16.3
(D19.3
(D19
(D19
(D18.2
(D17.9
(D16.6
/capita, US$ exchange rate
(D0.8
(D0.8
(D0.9
(D0.9
(D0.8
(D0.7
(D0.7
(D0.7
/capita, US$ purchasing power parity
(D0.6
(D0.7
(D0.8
(D0.8
(D0.8
(D0.7
(D0.7
(D0.6
% of total sales
(D0.2
(D0.2
(D0.2
(D0.2
(D0.2
(D0.2
(D0.2
(D0.1
N06A-AntidepressantsInformation on itemMillion of national currency units
(D464
(D438
(D441
(D433
(D445
(D464
(D506
(D549
Million US$ at exchange rate
(D418.3
(D329.1
(D327.8
(D331.9
(D332.5
(D322.6
(D348.2
(D412.4
Million US$, purchasing power parity
(D319.5
(D297.2
(D304.1
(D293.1
(D302.6
(D313.5
(D348
(D379.3
/capita, US$ exchange rate
(D17.8
(D13.8
(D13.6
(D13.5
(D13.3
(D12.7
(D13.6
(D16.1
/capita, US$ purchasing power parity
(D13.6
(D12.5
(D12.6
(D11.9
(D12.1
(D12.4
(D13.6
(D14.8
% of total sales
(D3.9
(D3.6
(D2.9
(D2.9
(D3
(D3
(D3
(D3.1
R-Respiratory systemInformation on itemMillion of national currency units
(D659
(D697
(D710
(D729
(D728
(D908
(D1 067
(D1 088
Million US$ at exchange rate
(D594
(D523.6
(D527.8
(D558.7
(D543.9
(D631.2
(D734.3
(D817.3
Million US$, purchasing power parity
(D453.7
(D473
(D489.6
(D493.4
(D495.1
(D613.6
(D733.9
(D751.6
/capita, US$ exchange rate
(D25.3
(D22
(D21.8
(D22.7
(D21.8
(D24.9
(D28.6
(D31.8
/capita, US$ purchasing power parity
(D19.3
(D19.9
(D20.2
(D20.1
(D19.8
(D24.2
(D28.6
(D29.3
% of total sales
(D5.5
(D5.7
(D4.6
(D4.9
(D4.9
(D5.8
(D6.4
(D6.2
R03-Drugs for obstructive airway diseasesInformation on itemMillion of national currency units
(D634
(D618
(D629
(D650
(D633
(D668
(D743
(D746
Million US$ at exchange rate
(D571.5
(D464.3
(D467.6
(D498.2
(D472.9
(D464.4
(D511.3
(D560.4
Million US$, purchasing power parity
(D436.5
(D419.4
(D433.7
(D439.9
(D430.5
(D451.4
(D511
(D515.3
/capita, US$ exchange rate
(D24.3
(D19.5
(D19.3
(D20.3
(D18.9
(D18.3
(D19.9
(D21.8
/capita, US$ purchasing power parity
(D18.6
(D17.6
(D17.9
(D17.9
(D17.2
(D17.8
(D19.9
(D20.1
% of total sales
(D5.3
(D5
(D4.1
(D4.4
(D4.2
(D4.3
(D4.5
(D4.2
Products not elsewhere classifiedInformation on itemMillion of national currency units
(D3 616
(D3 987
(D4 356
(D4 587
(D5 280
(D5 999
(D6 768
(D7 354
Million US$ at exchange rate
(D3 259.5
(D2 995.3
(D3 238.1
(D3 515.6
(D3 945
(D4 170.3
(D4 657.7
(D5 524.2
Million US$, purchasing power parity
(D2 489.5
(D2 705.5
(D3 003.8
(D3 104.5
(D3 590.9
(D4 053.7
(D4 654.9
(D5 080.2
/capita, US$ exchange rate
(D138.8
(D125.8
(D133.9
(D142.9
(D158
(D164.6
(D181.5
(D215.1
/capita, US$ purchasing power parity
(D106
(D113.6
(D124.2
(D126.2
(D143.8
(D160
(D181.4
(D197.8
% of total sales
(D30.4
(D32.5
(D28.5
(D31
(D35.4
(D38.6
(D40.7
(D41.9
Legend:
DDifference in methodology
Data extracted on 13 Apr 2024 18:35 UTC (GMT) from OECD.Stat